Navigation Links
Study looks at psychological impact of gene test for breast cancer
Date:10/2/2008

BRCA mutation. In all three groups, the women were less worried than before they were tested.

The study found that the women's beliefs about their inconclusive result had an important impact on their psychological adjustment. "For example, women who report feeling uncertain or ambivalent about their inconclusive DNA test result reported higher levels of worry and distress," Drs. Van Dijk and colleagues write. The women's beliefs about their inconclusive results were "very strongly related" to whether they had come to terms with their result and its implications for breast cancer risk.

The link between beliefs and psychological adjustment remained strong even after accounting for the women's levels of worry and distress. "Cancer-related worries and distress may provide an important but incomplete picture on how women adapt to their inconclusive result," according to the researchers. "[W]omen differ in whether they can cope with the uncertainty of an inconclusive result."

Other important factors included whether the women were actually tested themselves or had received inconclusive results from an affected relative who was tested. Women who were not personally tested were more likely to believe they might have inherited a BRCA mutation, which in turn was related to lower psychological adjustment.

Implications for Genetic Counseling

As in other genetic tests, the psychological impact of BRCA testing is an important consideration. Previous research has found that BRCA testing does not generally lead to high levels of psychological distress. However, few studies have focused on adjustment in the large number of women with inconclusive results.

Dr. van Dijk and colleagues believe their results highlight the role played by genetic counselors in ensuring that women accurately understand their BRCA testincluding the uncertainty associated with inconclusive results. They write, "Not only must women's expecta
'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UNC study on properties of carbon nanotubes, water could have wide-ranging implications
2. Sweat it out: UH study examines ability of sweat patches to monitor bone loss
3. Study reveals specific gene in adolescent men with delinquent peers
4. New study indicates link between weight gains during pregnancy and dieting history
5. Study: urban black bears live fast, die young
6. Researchers study how pistachios may improve heart health
7. Study reveals homeowner perceptions in fire-prone areas
8. Researchers study acoustic communication in deep-sea fish
9. CU-Boulder study suggests air quality regulations miss key pollutants
10. New study looks to define evangelicals and how they affect polling
11. £2 million study to reveal workings of dementia genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today its completion ... its adherence to current U.S. Food and Drug Administration ... smart device and smart phone application trials utilizing the ... "HITLAB is determined to improve global healthcare access, ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... N.M., Feb. 19, 2013A study by researchers from Los Alamos ... direct-acting antiviral agent in development for the treatment of hepatitis ... the fastest viral decline ever seen with anti-HCV drugs ... C virus affects about 150 million people worldwide. It is ...
... and higher education institutions is developing a network for ... help doctors to diagnose different types of possible cancerous ... The seven partners across four European countries, Spain, ... project, known as BIOPOOL, with a budget of 2,500,000 ...
... PARK, Pa. Identifying areas of malarial infection ... on the average monthly temperatures, according to a ... may also apply to environmentally temperature-dependent organisms other ... key driver of several of the essential mosquito ...
Cached Biology News:Computer modeling reveals how surprisingly potent hepatitis C drug works 2Data pooling in biobanks: The BIOPOOL project 2New approach alters malaria maps 2
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015  El ... abre hoy su llamada a nominaciones para 2015. Este ... ha hecho, o tiene el potencial para hacer, contribuciones ... nominaciones se aceptarán hasta el 15 de marzo de ...
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... July 7 Silence Therapeutics plc (AIM: SLN) ... United States patent 7,750,144, titled Methods and Compositions ... the United States Patent and Trademark Office (USPTO).  The ... (RNAi) agents having decreased off-target silencing activity through certain ...
... development of future molecular devices, new display technologies, and ... to play a primary role. ... interlocked structures that consist of a dumbell-shaped molecule whose ... behave as molecular "machines," with the ring moving along ...
... XIANYANG, China , July ... ) ("Biostar" or "the Company"), the,Xianyang-based manufacturer of a ... other pharmaceutical products, today,announced that Mr. Deyin "Bill" ... July 1, 2010 . Mr. Chen replaces Ms. ...
Cached Biology Technology:Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent 2Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent 3Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent 4Study measures single-molecule machines in action 2Biostar Pharmaceuticals, Inc. Appoints New Chief Financial Officer 2Biostar Pharmaceuticals, Inc. Appoints New Chief Financial Officer 3
...
... ESGRO Complete Derivation Kit is ... ES cells from delayed blastocysts in ... Clonal ... Delayed Blastocyst Incubation Medium Trypsin ...
Template and primers for preparation of internal control spots...
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
Biology Products: